The sale has been hampered by differences over price and the challenging vitamins part of the business, with both buyout firms pushing DSM to separate that unit from the disposal, said the people, who asked not to be identified because discussions are private.
Amsterdam-listed DSM-Firmenich would prefer to sell the entire business in one swoop, but bidders’ concerns around the vitamins part, which ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.